MedTrace Logo

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

NCT02501434 · Status: SUSPENDED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2022-03-04

No results posted yet for this study

Summary

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden. - STUDY IS TEMPORARILY SUSPENDED WITH PLAN TO RESUME SOON. NO SAFETY CONCERNS

Conditions

  • Aneurysmal Subarachnoid Hemorrhage
  • Neurobehavioral Manifestations
  • Vasospasm, Intracranial
  • Intracranial Aneurysm
  • Heparin-induced Thrombocytopenia Type II

Interventions

DRUG

Continuous Low-Dose IV Unfractionated Heparin Infusion

Continuous intravenous infusion of a low-dose unfractionated heparin drip

Sponsors & Collaborators

  • Indiana University School of Medicine

    collaborator OTHER

  • Robert F. James

    lead OTHER

Principal Investigators

  • Robert F James, MD · Indiana University

  • J Marc Simard, MD, PhD · University of Maryland

  • J Mocco, MD, MSc · Icahn School of Medicine at Mount Sinai

  • Kevin N Sheth, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2023-01-31
Completion
2024-01-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501434 on ClinicalTrials.gov